EFECT

Welcome to the Brand page for “EFECT”, which is offered here for Therapeutic, prophylactic preparations, and pharmaceutical preparations and agents for the treatment or prophylaxis of human diseases, disorders and conditions, cancer, auto immune and inflammatory diseases, rheumatoid arthritis, crohn's disease, multiple sclerosis, inflammatory connective tissue diseases, irritable bowel disease, irritable bowel syndrome, colitis, pelvic inflammatory disease, and scleroderma;effect;licensing of proprietary intellectual property;scientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment, and prophylaxis of human diseases, disorders and conditions, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, auto immune diseases, inflammatory diseases, and infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “EFECT” is believed to be currently owned by “ZYMEWORKS BC INC.”